Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2010 (2010), Article ID 121620, 4 pages
http://dx.doi.org/10.1155/2010/121620
Clinical Study

Early Primary Biliary Cirrhosis: A New Association with Erythema Nodosum of Unknown Origin

1Department of Medicine, School of Medicine, University of Thessaly, Thessaly, 41110 Larissa, Greece
2Research Group of Investigational Medicine, Institute of Biomedical Research and Technology, Centre for Research and Technology-Thessaly (CE.RE.TE.TH), 41222 Thessaly, Larissa, Greece

Received 6 April 2010; Accepted 22 June 2010

Academic Editor: Christian Trautwein

Copyright © 2010 Nikolaos K. Gatselis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Mana and J. Marcoval, “Erythema nodosum,” Clinics in Dermatology, vol. 25, no. 3, pp. 288–294, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. Y. K. Tay, “Erythema nodosum in Singapore,” Clinical and Experimental Dermatology, vol. 25, no. 5, pp. 377–380, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Kakourou, P. Drosatou, F. Psychou, K. Aroni, and P. Nicolaidou, “Erythema nodosum in children: a prospective study,” Journal of the American Academy of Dermatology, vol. 44, no. 1, pp. 17–21, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. M. D. Fox and R. A. Schwartz, “Erythema nodosum,” American Family Physician, vol. 46, no. 3, pp. 818–822, 1992. View at Google Scholar · View at Scopus
  5. A. Lleo, P. Invernizzi, I. R. Mackay, H. Prince, R.-Q. Zhong, and M. E. Gershwin, “Etiopathogenesis of primary biliary cirrhosis,” World Journal of Gastroenterology, vol. 14, no. 21, pp. 3328–3337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. M. Kaplan and M. E. Gershwin, “Primary biliary cirrhosis,” The New England Journal of Medicine, vol. 353, no. 12, pp. 1261–1273, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. E. I. Rigopoulou and G. N. Dalekos, “Molecular diagnostics of primary billary cirrhosis,” Expert Opinion on Medical Diagnostics, vol. 2, no. 6, pp. 621–634, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Invernizzi, A. Lleo, and M. Podda, “Interpreting serological tests in diagnosing autoimmune liver diseases,” Seminars in Liver Disease, vol. 27, no. 2, pp. 161–172, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. S. Gabeta, G. L. Norman, and G. L. Norman, “Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis,” Journal of Clinical Immunology, vol. 27, no. 4, pp. 378–387, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. K. Zachou, C. Liaskos, and C. Liaskos, “Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases,” Clinical Immunology, vol. 119, no. 2, pp. 203–212, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. E. I. Rigopoulou, E. T. Davies, and E. T. Davies, “Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis,” Gut, vol. 54, no. 4, pp. 528–532, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. Nakamura, H. Kondo, and H. Kondo, “Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis,” Hepatology, vol. 45, no. 1, pp. 118–127, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. S. Gabeta, G. L. Norman, and G. L. Norman, “IgA anti-b2GPI antibodies in patients with autoimmune liver diseases,” Journal of Clinical Immunology, vol. 28, no. 5, pp. 501–511, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. N. K. Gatselis, A. Stefos, C. Gioti, E. I. Rigopoulou, and G. N. Dalekos, “Primary biliary cirrhosis and Henoch-Schonlein purpura: report of two cases and review of the literature,” Liver International, vol. 27, no. 2, pp. 280–283, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. G. N. Dalekos, F. N. Skopouli, and E. V. Tsianos, “Primary biliary cirrhosis associated with anticardiolipin syndrome,” European Journal of Internal Medicine, vol. 6, no. 3, pp. 179–181, 1995. View at Google Scholar · View at Scopus
  16. G. S. Hatzis, G. E. Fragoulis, A. Karatzaferis, I. Delladetsima, C. Barbatis, and H. M. Moutsopoulos, “Prevalence and longterm course of primary biliary cirrhosis in primary Sjögren's syndrome,” Journal of Rheumatology, vol. 35, no. 10, pp. 2012–2016, 2008. View at Google Scholar · View at Scopus
  17. H. Iwadate, H. Ohira, and H. Ohira, “A case of primary biliary cirrhosis complicated by Behçet's disease and palmoplantar pustulosis,” World Journal of Gastroenterology, vol. 12, no. 13, pp. 2136–2138, 2006. View at Google Scholar · View at Scopus
  18. N. Gatselis, E. Malli, G. Papadamou, E. Petinaki, and G. N. Dalekos, “Direct detection of Cardiobacterium hominis in serum from a patient with infective endocarditis by broad-range bacterial PCR,” Journal of Clinical Microbiology, vol. 44, no. 2, pp. 669–672, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. E. I. Rigopoulou, E. T. Davies, and E. T. Davies, “Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis,” Liver International, vol. 27, no. 9, pp. 1226–1231, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. E. I. Rigopoulou, D.-P. Bogdanos, C. Liaskos, A. Koutsoumpas, H. Baum, D. Vergani, and G. N. Dalekos, “Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis,” Clinica Chimica Acta, vol. 380, no. 1-2, pp. 118–121, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. S. Hohenester, R. P. J. Oude-Elferink, and U. Beuers, “Primary biliary cirrhosis,” Seminars in Immunopathology, vol. 31, no. 3, pp. 283–307, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. M. Koulentaki, D. Ioannidou, and D. Ioannidou, “Dermatological manifestations in primary biliary cirrhosis patients: a case control study,” American Journal of Gastroenterology, vol. 101, no. 3, pp. 541–546, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. H. C. Mitchison, M. F. Bassendine, and A. Hendrick, “Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?” Hepatology, vol. 6, no. 6, pp. 1279–1284, 1986. View at Google Scholar · View at Scopus
  24. J. V. Metcalf, H. C. Mitchison, J. M. Palmer, D. E. Jones, M. F. Bassendine, and O. F. W. James, “Natural history of early primary biliary cirrhosis,” The Lancet, vol. 348, no. 9039, pp. 1399–1402, 1996. View at Publisher · View at Google Scholar · View at Scopus